Transcripts IRLAB Therapeutics AB

Stocks

Market Closed - Nasdaq Stockholm 17:00:00 01/09/2026 BST			5-day change	1st Jan Change
1.764 ^SEK	-1.56%		+1.03%	-10.46%

08-28	Redeye sets a justified value of 6.60 kronor for Irlab, partnerships remain in focus	FW
08-26	IRLAB Therapeutics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

27/08/25	IRLAB Therapeutics AB, Q2 2025 Earnings Call, Aug 27, 2025
07/05/25	IRLAB Therapeutics AB, Q1 2025 Earnings Call, May 07, 2025
28/03/25	IRLAB Therapeutics AB - Special Call
12/02/25	IRLAB Therapeutics AB, 2024 Earnings Call, Feb 12, 2025
04/12/24	IRLAB Therapeutics AB - Special Call
30/10/24	IRLAB Therapeutics AB, Q3 2024 Earnings Call, Oct 30, 2024
10/07/24	IRLAB Therapeutics AB, H1 2024 Earnings Call, Jul 10, 2024
08/05/24	IRLAB Therapeutics AB, Q1 2024 Earnings Call, May 08, 2024
07/02/24	IRLAB Therapeutics AB, 2023 Earnings Call, Feb 07, 2024
25/10/23	IRLAB Therapeutics AB, Nine Months 2023 Earnings Call, Oct 25, 2023
17/10/23	IRLAB Therapeutics AB - Analyst/Investor Day
11/10/23	IRLAB Therapeutics AB Presents at Redeye Neurology Seminar, Oct-11-2023 10:10 AM
30/08/23	IRLAB Therapeutics AB, Q2 2023 Earnings Call, Aug 30, 2023
22/08/23	IRLAB Therapeutics AB - Special Call
10/05/23	IRLAB Therapeutics AB, Q1 2023 Earnings Call, May 10, 2023
23/02/23	IRLAB Therapeutics AB, 2022 Earnings Call, Feb 23, 2023
18/01/23	IRLAB Therapeutics AB - Special Call
09/11/22	IRLAB Therapeutics AB, Nine Months 2022 Earnings Call, Nov 09, 2022